Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1977 Apr;74(4):1697–1701. doi: 10.1073/pnas.74.4.1697

Immunoprevention of x-ray-induced leukemias in the C57BL mouse.

R L Peters, B Sass, J R Stephenson, I K Al-Ghazzouli, S Hino, R M Donahoe, M Kende, S A Aaronson, G J KElloff
PMCID: PMC430860  PMID: 193112

Abstract

An attempt to prevent irradiation-induced thymic lymphomas in C57BL mice was made by inducing active immunity to endogenous type-C virus with inactivated Rauscher murine leukemia virus (MuLV) or inactivated Gross MuLV or by transferring passive immunity to endogenous type-C virus with goat anti-Gross MuLV IgG. Control groups received the following immunogen or treatment: inactivated simian sarcoma virus, complete Freund's adjuvant, normal goat IgG, and diluent, in both irradiated and nonirradiated C57BL mice Active immunity to the 70,000 molecular weight glycoprotein AKR-gp70 by immunization with Rauscher MuLV and passive immunity to AKR-gp70 by passive transfer of goat anti-Gross-MuLV IgG was measurable throughout some of the latent period of tumor development; in these two groups a significant reduction in tumor incidence was observed, as compared to the other experimental and control groups. Thus, the present findings support the concept of a type-C virus etiology of irradiation-induced leukemias and demonstrate the applicability of immunologic techniques directed against the endogenous type-C virus in the prevention of this disease.

Full text

PDF
1697

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Declève A., Lieberman M., Ihle J. N., Kaplan H. S. Biological and serological characterization of radiation leukemia virus. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4675–4679. doi: 10.1073/pnas.73.12.4675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Donahoe R. M., Peters R. L., VanVleck R., Huebner R. J., Kelloff G. J. Development of a lymphocyte transformation microassay for murine leukemia virus. J Natl Cancer Inst. 1976 Jan;56(1):51–57. doi: 10.1093/jnci/56.1.51. [DOI] [PubMed] [Google Scholar]
  3. GROSS L. Pathogenic properties, and "vertical" transmission of the mouse leukemia agent. Proc Soc Exp Biol Med. 1951 Oct;78(1):342–348. doi: 10.3181/00379727-78-19068. [DOI] [PubMed] [Google Scholar]
  4. Hebert G. A., Pelham P. L., Pittman B. Determination of the optimal ammonium sulfate concentration for the fractionation of rabbit, sheep, horse, and goat antisera. Appl Microbiol. 1973 Jan;25(1):26–36. doi: 10.1128/am.25.1.26-36.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hino S., Stephenson J. R., Aaronson S. A. Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol. 1976 Jun;18(3):933–941. doi: 10.1128/jvi.18.3.933-941.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Huebner R. J., Gilden R. V., Lane W. T., Toni R., Trimmer R. W., Hill P. R. Suppression of murine type-C RNA virogenes by type-specific oncornavirus vaccines: prospects for prevention of cancer. Proc Natl Acad Sci U S A. 1976 Feb;73(2):620–624. doi: 10.1073/pnas.73.2.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Huebner R. J., Gilden R. V., Toni R., Hill R. W., Trimmer R. W., Fish D. C., Sass B. Prevention of spontaneous leukemia in AKR mice by type-specific immunosuppression of endogenous ecotropic virogenes. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4633–4635. doi: 10.1073/pnas.73.12.4633. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ihle J. N., Domotor J. J., Jr, Bengali K. M. Characterization of the type and group specificities of the immune response in mice to murine leukemia viruses. J Virol. 1976 Apr;18(1):124–131. doi: 10.1128/jvi.18.1.124-131.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ihle J. N., Joseph D. R., Pazmino N. H. Radiation leukemia in C57BL/6 mice. II. Lack of ecotropic virus expression in the majority of lymphomas. J Exp Med. 1976 Dec 1;144(6):1406–1423. doi: 10.1084/jem.144.6.1406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. KAPLAN H. S., BROWN M. B. A quantitative dose-response study of lymphoid-tumor development in irradiated C 57 black mice. J Natl Cancer Inst. 1952 Aug;13(1):185–208. [PubMed] [Google Scholar]
  11. Kaplan H. S. On the natural history of the murine leukemias: presidential address. Cancer Res. 1967 Aug;27(8):1325–1340. [PubMed] [Google Scholar]
  12. Kelloff G. J., Peters R. L., Donahoe R. M., Ghazzouli I., Sass B., Nims R. M., Huebner R. J. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice. Cancer Res. 1976 Feb;36(2 Pt 2):622–630. [PubMed] [Google Scholar]
  13. Kelloff G. J., Peters R. L., Donahoe R. M., Stephenson J. R., Aaronson S. A. Natural occurrence of tumors in mouse strains with different xenotropic and ecotropic endogenous viruses. J Natl Cancer Inst. 1976 Jul;57(1):85–89. doi: 10.1093/jnci/57.1.85. [DOI] [PubMed] [Google Scholar]
  14. Klement V., Rowe W. P., Hartley J. W., Pugh W. E. Mixed culture cytopathogenicity: a new test for growth of murine leukemia viruses in tissue culture. Proc Natl Acad Sci U S A. 1969 Jul;63(3):753–758. doi: 10.1073/pnas.63.3.753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LIEBERMAN M., KAPLAN H. S. Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science. 1959 Aug 14;130(3372):387–388. doi: 10.1126/science.130.3372.387. [DOI] [PubMed] [Google Scholar]
  16. Lee J. C., Ihle J. N., Huebner R. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus. Proc Natl Acad Sci U S A. 1977 Jan;74(1):343–347. doi: 10.1073/pnas.74.1.343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Peebles P. T. An in vitro focus-induction assay for xenotropic murine leukemia virus, feline leukemia virus C, and the feline--primate viruses RD-114/CCC/M-7. Virology. 1975 Sep;67(1):288–291. doi: 10.1016/0042-6822(75)90427-4. [DOI] [PubMed] [Google Scholar]
  18. Peters R. L., Spahn G. J., Rabstein L. S., Kelloff G. J., Huebner R. J. Oncogenic potential of murine C-type RNA virus passaged directly from naturally occurring tumors of the BALB-cCr mouse. J Natl Cancer Inst. 1973 Aug;51(2):621–630. [PubMed] [Google Scholar]
  19. Rowe W. P., Pugh W. E., Hartley J. W. Plaque assay techniques for murine leukemia viruses. Virology. 1970 Dec;42(4):1136–1139. doi: 10.1016/0042-6822(70)90362-4. [DOI] [PubMed] [Google Scholar]
  20. Stephenson J. R., Greenberger J. S., Aaronson S. A. Oncogenicity of an endogenous C-type virus chemically activated from mouse cells in culture. J Virol. 1974 Jan;13(1):237–240. doi: 10.1128/jvi.13.1.237-240.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stephenson J. R., Peters R. L., Hino S., Donahoe R. M., Long L. K., Aaronson S. A., Kelloff G. J. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol. 1976 Sep;19(3):890–898. doi: 10.1128/jvi.19.3.890-898.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tronick S. R., Stephenson J. R., Aaronson S. A. Immunological characterization of a low molecular weight polypeptide of murine leukemia virus. Virology. 1973 Jul;54(1):199–206. doi: 10.1016/0042-6822(73)90129-3. [DOI] [PubMed] [Google Scholar]
  23. Whitmire C. E., Huebner R. J. Inhibition of chemical carcinogenesis by viral vaccines. Science. 1972 Jul 7;177(4043):60–61. doi: 10.1126/science.177.4043.60. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES